Regeneron Genetics Center Surpasses 250K Exomes Sequenced,and Ramping Up

The Regeneron Genetics Center (RGC) has surpassed 250,000 exomes sequenced since its creation three years ago—with a vision of sequencing up to double that number.RGC, a wholly-owned subsidiary of Regeneron Pharmaceuticals established in 2014, has increased its sequencing rate since then to 200,000 exomes per year, with plans to ramp up to between 400,000 to 500,000 people a year.“We were going to do 100,000 in five years, which means that we should have been at 60,000” by now,